ProBio and Kun Tuo announce CDMO-CRO collaboration for advanced therapies
ProBio and Kun Tuo announced a strategic collaboration combining manufacturing, development and clinical operations expertise for advanced therapies, aimed at accelerating investigator-initiated trials and clinical execution in China.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.